喘和COPD患者中的鼻内类固醇使用和COVID-19死亡率:一项回顾性队列研究
Virginia Hernandez Santiago1, Adeniyi Francis Fagbamigbe1, Frank M Sullivan1
1School of Medicine, University of St Andrews, St Andrews, United Kingdom.
鼻内皮质类固醇 (INCS) 在一般或慢性呼吸道疾病人群中没有显著影响COVID-19死亡率. 然而,INCS使用与所有研究组的全因死亡率降低有关.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
背景情况:
- 系统性皮质类固醇用于严重的急性呼吸困扰综合征.
- 吸入性皮质类固醇可能会防止COVID-19.
- 鼻内皮质类固醇 (INCS) 对COVID-19结局的影响在很大程度上是未知的.
研究的目的:
- 评估之前长期INCS暴露对COVID-19死亡率的影响.
- 评估这种影响在慢性呼吸道疾病患者和普通人群中的影响.
主要方法:
- 追溯队列研究的设计.
- 考克斯回归模型用于估计危险比率 (HRs) 和95%置信区间 (CI).
- 根据年龄,性别,贫困,恶化和并发症进行调整.
主要成果:
- 在一般人群,COPD或喘队伍中,INCS暴露与COVID-19死亡率没有显著关联.
- INCS暴露与所有原因死亡率的降低显著相关:一般人群中40%,COPD患者中30%,喘患者中50%.
结论:
- 鼻腔内皮质类固醇的使用似乎不会对COVID-19死亡率产生不利影响.
- 需要进一步的研究来了解INCS在COVID-19病毒载荷,炎症和ACE2基因表达中的作用.
更多相关视频
03:40Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
09:03Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Inhaled Medications
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
